Literature DB >> 16927074

The world according to poly(ADP-ribose) polymerase (PARP)--update 2006.

Eberhard Barth1, Peter Radermacher, Csaba Szabó.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16927074     DOI： 10.1007/s00134-006-0336-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  27 in total

1.  Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst.

Authors:  Irina G Obrosova; Jon G Mabley; Zsuzsanna Zsengellér; Tamara Charniauskaya; Omorodola I Abatan; John T Groves; Csaba Szabó
Journal:  FASEB J       Date:  2004-12-20       Impact factor: 5.191

2.  Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.

Authors:  Jennifer Kaplan; Michael O'Connor; Paul W Hake; Basilia Zingarelli
Journal:  Shock       Date:  2005-03       Impact factor: 3.454

Review 3.  Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in the pathogenesis of liver injury.

Authors:  Domokos Gero; Csaba Szabó
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

Authors:  L Liaudet; F G Soriano; E Szabó; L Virág; J G Mabley; A L Salzman; C Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

5.  Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.

Authors:  J P Roesner; D A Vagts; T Iber; C Eipel; B Vollmar; G F E Nöldge-Schomburg
Journal:  Intensive Care Med       Date:  2006-08-23       Impact factor: 17.440

6.  Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5'-diphosphate-ribose) polymerase.

Authors:  Gábor Szabó; Pál Soós; Susanne Mandera; Ulrike Heger; Christa Flechtenmacher; Leila Seres; Zsuzsanna Zsengellér; Falk-Udo Sack; Csaba Szabó; Siegfried Hagl
Journal:  Crit Care Med       Date:  2004-12       Impact factor: 7.598

7.  Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase.

Authors:  C M Simbulan-Rosenthal; D H Ly; D S Rosenthal; G Konopka; R Luo; Z Q Wang; P G Schultz; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

8.  Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.

Authors:  Pál Pacher; Lucas Liaudet; Péter Bai; Jon G Mabley; Pawel M Kaminski; László Virág; Amitabha Deb; Eva Szabó; Zoltán Ungvári; Michael S Wolin; John T Groves; Csaba Szabó
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

9.  Gender differences in the endotoxin-induced inflammatory and vascular responses: potential role of poly(ADP-ribose) polymerase activation.

Authors:  Jon G Mabley; Eszter M Horváth; Kanneganti G K Murthy; Zsuzsanna Zsengellér; Anne Vaslin; Rita Benko; Márk Kollai; Csaba Szabó
Journal:  J Pharmacol Exp Ther       Date:  2005-08-03       Impact factor: 4.030

10.  3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock.

Authors:  A Szabó; P Hake; A L Salzman; C Szabó
Journal:  Shock       Date:  1998-11       Impact factor: 3.454
View more
  4 in total

Review 1.  Year in review in Intensive Care Medicine, 2006. I. Experimental studies. Clinical studies: brain injury, renal failure and endocrinology.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2006-12-19       Impact factor: 17.440

2.  Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury.

Authors:  Fiona D Saunders; Martin Westphal; Perenlei Enkhbaatar; Jianpu Wang; Konrad Pazdrak; Yoshimitsu Nakano; Atsumori Hamahata; Collette C Jonkam; Matthias Lange; Rhykka L Connelly; Gabriela A Kulp; Robert A Cox; Hal K Hawkins; Frank C Schmalstieg; Eszter Horvath; Csaba Szabo; Lillian D Traber; Elbert Whorton; David N Herndon; Daniel L Traber
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-04       Impact factor: 5.464

3.  Ceftazidime improves hemodynamics and oxygenation in ovine smoke inhalation injury and septic shock.

Authors:  Marc O Maybauer; Dirk M Maybauer; John F Fraser; Lillian D Traber; Martin Westphal; Robert A Cox; Ruksana Huda; Yoshimitsu Y Nakano; Perenlei Enkhbaatar; Hal K Hawkins; David N Herndon; Daniel L Traber
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

4.  Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?

Authors:  Martin Matejovic; Peter Radermacher
Journal:  Crit Care       Date:  2010-05-06       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.